Are you Dr. Milano?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 17 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-677-5925
Summary
- Dr. Filippo Milano, MD is a hematologist in Seattle, Washington. He is currently licensed to practice medicine in Washington and Idaho. He is affiliated with Fred Hutch Cancer Center and UW Medicine/University of Washington Medical Center.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2013 - 2016
Sapienza University of RomeClass of 2001
Certifications & Licensure
ID State Medical License 2022 - 2025
WA State Medical License 2009 - 2025
Clinical Trials
- Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes Start of enrollment: 2022 May 10
- Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers Start of enrollment: 2022 Oct 06
- US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia Start of enrollment: 2020 Nov 13
- Join now to see all
Publications & Presentations
PubMed
- 29 citationsIncidence, Risk Factors, and Outcomes of Idiopathic Pneumonia Syndrome after Allogeneic Hematopoietic Cell TransplantationDavid S. Wenger, Matthew Triplette, Kristina Crothers, Guang-Shing Cheng, Joshua A. Hill
Biology of Blood and Marrow Transplantation. 2019-10-09 - 111 citationsFactors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignanciesJordan Gauthier, Evandro D. Bezerra, Alexandre V. Hirayama, Salvatore Fiorenza, Alyssa Sheih
Blood. 2021-01-21 - 25 citationsγ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, ...Andrew J Cowan, Margot J Pont, Blythe D Sather, Cameron J Turtle, Brian G Till
The Lancet. Oncology. 2023-07-01
Press Mentions
Testing Cord Blood Transplants as a Cure for Leukemia — and HIVMarch 10th, 2022
Fred Hutch at ASH: Press Briefing on CAR T-cell Therapy, CRISPR for Blood Disorders, MoreNovember 26th, 2018
Cord Blood Transplantation Proves Beneficial in High-Risk Patients with LeukemiaOctober 10th, 2017- Join now to see all
